Metabolic-Fit / 100
Vyvron review
"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel." That sentence does something almost nothing else on this page manages: it names the billing period in the same breath as the price, so you can see that a year is thirteen charges rather than twelve. Then you go looking for the terms of use, and find that the link returns the homepage with a different title on it. There is no terms of use.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Vyvron at a glance
- Semaglutide
- $149 per 4 weeks
- Tirzepatide
- $199 per 4 weeks
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored Vyvron
Every factor comes from Vyvron's own published pricing, disclosures and oversight, and the six combine into the 47/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- vyvron.com
Read on 18 August 2026. Vyvron LLC prices compounded semaglutide at $149 and tirzepatide at $199, and does something unusual with those figures: it prints the billing period in the same sentence — "per 4 weeks, billed every 4 weeks; auto-renews until you cancel". A four-week cycle is thirteen charges a year, so the annual cost is $1,937 and $2,587 at these rates, and the site says both are founding prices that will return to $179 and $249. It carries a LegitScript badge and states that there are no hidden fees and cancellation is available at any time. Against that: its legal pages do not exist. Requests for /terms, /privacy, /privacy-policy and /shipping-policy each return the homepage with a legal-sounding title above marketing copy — similarity to the homepage of 0.993 to 0.995, so nothing but a close comparison would catch it. A site that links to a terms of use and has none is publishing a document it does not have. The scarcity counter also reads "100 of 100 founding spots left" on both products, unchanged. No state list and no compounding pharmacy are published, and the company has no FDA warning letter.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $149 | Per 4 weeks, auto-renewing"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel" — the founding rate. The site says the price returns to $179. Thirteen charges a year, not twelve. |
| Compounded tirzepatide | $199 | Per 4 weeks, auto-renewing"$199 per 4 weeks" at the founding rate, returning to $249. Same four-week cycle, stated in the same sentence as the price. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Vyvron's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- States the four-week cycle in the same sentence as the price, so the year is countable
- Says outright that it auto-renews until canceled, rather than leaving that to the small print
- Prices both molecules separately, at $149 and $199 per four weeks
- Names its operating company, Vyvron LLC, and carries a LegitScript badge
- "No hidden fees · Cancel anytime · Provider-guided" is stated on both products
The caveats
- ⛔ Its terms of use, privacy policy and shipping policy do not exist — each link returns the homepage under a legal title
- A four-week cycle is thirteen charges a year: $1,937 for semaglutide, not the $1,788 a monthly reading suggests
- Both prices are "founding" rates the site says will rise to $179 and $249
- The scarcity counter reads "100 of 100 founding spots left" on both products — it has not moved
- No state list is published
- No compounding pharmacy is named
Vyvron for mothers: our verdict
"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel." That sentence does something almost nothing else on this page manages: it names the billing period in the same breath as the price, so you can see that a year is thirteen charges rather than twelve. Then you go looking for the terms of use, and find that the link returns the homepage with a different title on it. There is no terms of use. It runs about $149/4 weeks — toward the affordable end of what we track.
We weigh Vyvron the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Vyvron costs, in full
- Compounded semaglutide — Per 4 weeks, auto-renewing: $149/4 wks
- Compounded tirzepatide — Per 4 weeks, auto-renewing: $199/4 wks
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
Vyvron says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Vyvron prescribes
Vyvron prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Vyvron fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Vyvron is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants the billing cycle stated plainly and can live without any legal documents at all.
Alternatives to Vyvron
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Vyvron
Head-to-head & alternatives
Vyvron, answered
- How much does Vyvron cost?
- At last review, Vyvron's lowest ongoing compounded rate was about $149 a month — $149 per 4 weeks for semaglutide, $199 per 4 weeks for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Vyvron safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Vyvron is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Vyvron offer both semaglutide and tirzepatide?
- Yes — Vyvron offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Vyvron rank for mothers?
- Vyvron scores 47/100 on our Metabolic-Fit Score and sits at #132. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Vyvron's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.